NORTHERN TRUST CORP - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$19,386,547
-23.4%
1,576,142
+0.1%
0.00%
-20.0%
Q2 2023$25,315,296
-6.1%
1,575,314
+1.7%
0.01%0.0%
Q1 2023$26,971,694
+87.5%
1,549,207
-0.5%
0.01%
+66.7%
Q4 2022$14,382,207
+1.8%
1,556,516
-5.2%
0.00%0.0%
Q3 2022$14,130,000
+37.8%
1,641,073
+30.4%
0.00%
+50.0%
Q2 2022$10,256,000
-43.9%
1,258,587
-16.4%
0.00%
-33.3%
Q1 2022$18,287,000
-65.5%
1,505,064
-3.1%
0.00%
-66.7%
Q4 2021$52,979,000
-29.9%
1,552,736
-0.9%
0.01%
-30.8%
Q3 2021$75,592,000
+5.8%
1,567,001
-1.0%
0.01%0.0%
Q2 2021$71,479,000
-5.6%
1,582,464
+0.8%
0.01%
-7.1%
Q1 2021$75,692,000
-9.2%
1,569,396
+1.3%
0.01%
-12.5%
Q4 2020$83,401,000
+45.9%
1,549,050
-0.1%
0.02%
+23.1%
Q3 2020$57,174,000
+14.1%
1,549,839
-4.2%
0.01%
+8.3%
Q2 2020$50,115,000
+23.4%
1,617,664
+9.9%
0.01%0.0%
Q1 2020$40,622,000
-12.6%
1,471,276
-7.4%
0.01%
+20.0%
Q4 2019$46,484,000
+49.1%
1,589,220
-2.5%
0.01%
+42.9%
Q3 2019$31,176,000
-1.5%
1,630,559
+13.0%
0.01%
-12.5%
Q2 2019$31,654,000
+12.2%
1,442,753
+4.6%
0.01%
+14.3%
Q1 2019$28,216,000
+97.3%
1,379,093
+21.6%
0.01%
+75.0%
Q4 2018$14,300,000
-18.6%
1,133,992
-1.0%
0.00%0.0%
Q3 2018$17,575,000
+34.2%
1,144,946
+14.6%
0.00%
+33.3%
Q2 2018$13,094,000
+64.1%
998,807
+2.2%
0.00%
+50.0%
Q1 2018$7,977,000
-6.7%
977,514
+1.3%
0.00%0.0%
Q4 2017$8,547,000
-21.7%
964,594
-1.6%
0.00%
-33.3%
Q3 2017$10,913,000
+24.3%
980,484
+0.1%
0.00%
+50.0%
Q2 2017$8,780,000
+25.7%
979,841
+10.6%
0.00%0.0%
Q1 2017$6,987,000
-6.6%
885,564
+1.4%
0.00%0.0%
Q4 2016$7,482,000
+1.5%
872,975
-2.7%
0.00%0.0%
Q3 2016$7,373,000
+4.1%
896,899
+1.8%
0.00%0.0%
Q2 2016$7,084,000
+37.0%
881,140
+12.3%
0.00%0.0%
Q1 2016$5,169,000
-14.5%
784,755
+2.2%
0.00%0.0%
Q4 2015$6,043,000
+59.2%
767,834
+15.9%
0.00%
+100.0%
Q3 2015$3,796,000
+600.4%
662,568
+560.7%
0.00%
Q2 2015$542,000
+8.0%
100,283
-6.7%
0.00%
Q1 2015$502,000
+12.1%
107,5180.0%0.00%
Q4 2014$448,000
-25.3%
107,518
-6.7%
0.00%
Q3 2014$600,000
-50.1%
115,203
-68.2%
0.00%
Q2 2014$1,202,000
-24.9%
362,120
-21.5%
0.00%
-100.0%
Q1 2014$1,600,000
-2.4%
461,461
+1.8%
0.00%0.0%
Q4 2013$1,640,000
+23.3%
453,232
+2.2%
0.00%
Q3 2013$1,330,000
+87.3%
443,691
+148.8%
0.00%
Q2 2013$710,000178,3470.00%
Other shareholders
NEOGENOMICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 396,327$8,109,0006.56%
Cowen Prime Services LLC 584,766$11,964,0006.20%
1492 Capital Management LLC 269,488$5,514,0004.67%
First Light Asset Management, LLC 1,604,611$32,830,0004.27%
PERKINS CAPITAL MANAGEMENT INC 264,650$5,415,0003.56%
FALCON POINT CAPITAL, LLC 219,992$4,501,0002.45%
Granite Investment Partners, LLC 1,764,090$36,093,0002.05%
Ranger Investment Management 1,209,535$24,747,0001.79%
EMERALD ADVISERS, LLC 1,878,901$38,442,0001.56%
EMERALD MUTUAL FUND ADVISERS TRUST 1,875,759$38,378,0001.54%
View complete list of NEOGENOMICS INC shareholders